YUHSpace: Dept. of Radiation Oncology (방사선종양학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Radiation Oncology (방사선종양학교실)

Dept. of Radiation Oncology (방사선종양학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Vers...

Jang, Jin-Young ; Han, Youngmin ; Lee, Hongeun ; Kim, Sun-Whe ; Kwon, Wooil ;... ANNALS OF SURGERY, Vol.268(2) : 215-222, 2018

Phase II trial of concurrent radiation and weekly cisplatin followed by ...

Seok Jin Kim ; Kihyun Kim ; Byung Soo Kim ; Chul Yong Kim ; Cheolwon Suh ; Jo... JOURNAL OF CLINICAL ONCOLOGY, Vol.27(35) : 6027-6032, 2009

PDF

Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Th...

Ann H. Klopp ; Anamaria R. Yeung ; Snehal Deshmukh ; Karen M. Gil ; Lari Wenz... JOURNAL OF CLINICAL ONCOLOGY, Vol.36(24) : 2538-2544, 2018

This table browses all dspace content
Issue Date	Title	Journal Title
2012	Radiation pneumonitis in breast cancer patients who received radiotherapy using the partially wide tangent technique after breast conserving surgeryconserving surgery	JOURNAL OF BREAST CANCER
2012	Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2012	Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer	EUROPEAN RADIOLOGY
2012	Reirradiation to the pelvis for recurrent rectal cancer	JOURNAL OF SURGICAL ONCOLOGY
2012	The optimal selection of radiotherapy treatment for hepatocellular carcinoma	GUT AND LIVER
2012	CD11b+ Gr1+ bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice	HEPATOLOGY
2012	Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma	JOURNAL OF RADIATION RESEARCH
2012	Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2012	Pancreatoduodenectomy following neoadjuvant chemoradiation therapy in uncinate process pancreatic cancer	PANCREAS
2011	Radiosensitizers in hepatocellular carcinoma	SEMINARS IN RADIATION ONCOLOGY
2011	Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011	Comparison of treatment outcome between breast-conservation surgery with radiation and total mastectomy without radiation in patients with one to three positive axillary lymph nodes	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011	Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011	Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model.	KOREAN JOURNAL OF RADIOLOGY
2011	Comparison of elective inguinal node irradiation techniques in anal cancer	RADIATION ONCOLOGY JOURNAL
2011	Attitudes of cancer patients, family caregivers, oncologists and members of the general public toward critical interventions at the end of life of terminally ill patients.	CANADIAN MEDICAL ASSOCIATION JOURNAL
2011	18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.	CANCER
2011	Treatment of recurrent hepatocellular carcinoma after liver transplantation	ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
2011	18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer.	JOURNAL OF SURGICAL ONCOLOGY
2011	A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results.	LUNG CANCER